Table 3

Time trends in lymphoma incidence rates by WHO subtype in Manitoba, Canada (1984–2013)

Lymphoma classificationMenWomen
Trend 1Trend 2AAPC (95% CI) for the full period (1984–2013)Trend 1Trend 2AAPC (95% CI) for the full period (1984–2013)
YearsEAPC
(95% CI)
YearsEAPC
(95% CI)
YearsEAPC
(95% CI)
YearsEAPC
(95% CI)
Lymphoid neoplasms1984 ̶ 20012.3
(1.7 to 2.9)
2001 ̶ 20130.2
(−0.7 too 1.1)
1.4
(0.9 to 1.9)
1984 ̶ 20042.4
(1.8 to 2.9)
2004 ̶ 2013−1.8
(−3.3 to −0.2)
1.3
(0.8 to 1.7)
HL−0.1
(−1.1 to 1.0)
−0.3
(−1.6 to 1.0)
NHL1984 ̶ 19984.2
(3.2 to 5.2)
1998 ̶ 20130.6
(−0.1 to 1.3)
2.3
(1.7 to 2.9)
1984 ̶ 20014.3
(3.3 to 5.2)
2001 ̶ 2013−1.0
(−2.2 to 0.2)
2.0
(1.4 to 2.6)
CLL/SLL1984 ̶ 20101.8
(1.0 to 2.5)
2010 ̶ 2013−10.1
(−29.0 to 9.3)
0.5
(−1.5 to 2.5)
1984 ̶ 20053.6
(2.3 to 5.0)
2005 to 2013−7.7
(−12.4 to −2.7)
1.3
(0.1 to 2.5)
DLBCL4.0
(3.1 to 4.8)
1984–199410.7
(5.5 to 16.2)
1994 to 20132.6
(1.3 to 3.9)
4.1
(3.1 to 5.1)
FL1984 ̶ 20033.5
(1.8 to 5.3)
2003 ̶ 2013−3.0
(−6.3 to 0.4)
1.2 (0.3 to 2.8)1.0
(−0.0 to 2.0)
PCN0.6
(0.1 to 1.2)
0.5
(−0.2 to 1.3)
  • AAPC, average annual percentage change; CLL/SLL, chronic/small lymphocytic leukaemia/lymphoma; DLBCL, diffuse large B cell lymphoma; EAPC, estimated annual percentage change; FL, follicular lymphoma; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; PCN, plasma cell neoplasm.